NCT06629675 Make Every Step Count: Personalised Music Feedback to Walking for People Living With COPD
| NCT ID | NCT06629675 |
| Status | Recruiting |
| Phase | — |
| Sponsor | University of Leicester |
| Condition | Chronic Obstructive Pulmonary Disease (COPD) |
| Study Type | INTERVENTIONAL |
| Enrollment | 30 participants |
| Start Date | 2025-04-20 |
| Primary Completion | 2025-09-12 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 30 participants in total. It began in 2025-04-20 with a primary completion date of 2025-09-12.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Pulmonary Rehabilitation (PR) is an evidence-based intervention to effectively manage the physiological and psychological effects of Chronic Obstructive Pulmonary Disease (COPD). The aims of PR are to improve symptoms of COPD, increase exercise capacity, increase independency, improve overall behaviour related to health (like exercising more), and enhance quality of life. The cornerstone of PR programmes is aerobic exercise prescription. Typically, walking exercise is used, and the prescription is individualised for each patient based on their maximal walking exercise capacity. However, adherence to walking exercise is challenging for service users, particularly when unsupervised at home. The use of music during exercise shows promise as a tool to decrease the perception of fatigue and increase motivation, but the integration of music via smartphone applications to support walking exercise adherence during PR has not been explored. This project aims to assess if a new mobile application BeatClearWalker (BCW) intervention is practical, acceptable, and effectively used by people living with COPD. The app is designed to help people living with COPD attending PR adhere to their prescribed walking pace during exercise. The BCW app provides real-time, personalised music feedback through music degradation to optimise the dose of walking exercise.
Eligibility Criteria
Inclusion Criteria: * Willing and able to provide informed consent for participation in the study. * The patient is referred for PR at the UHL. * The patient has a confirmed diagnosis of COPD using spirometry (based on GOLD criteria) * Male or female, aged 18+ years. * Able to communicate in written and spoken English. Exclusion Criteria: * Unable to provide valid informed consent. * Lack of motivation to participate in PR programme. * Any-contra-indications absolute or relative to exercise training. * Has had a cardiac event within last 6 weeks * Severe psychiatric disorders * Patients with a history of MRSA +ve screens (patients can be assessed and given an exercise programme but cannot attend the classes. Patients need to have 3 consecutive -ve MRSA swabs before they can attend). * Unable to understand written or spoken English.
Contact & Investigator
Mark Orme, PhD
PRINCIPAL INVESTIGATOR
University of Leicester
Frequently Asked Questions
Who can join the NCT06629675 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Chronic Obstructive Pulmonary Disease (COPD). Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06629675 currently recruiting?
Yes, NCT06629675 is actively recruiting participants. Contact the research team at oaea3@leicester.ac.uk for enrollment information.
Where is the NCT06629675 trial being conducted?
This trial is being conducted at Leicester, United Kingdom, Leicester, United Kingdom.
Who is sponsoring the NCT06629675 clinical trial?
NCT06629675 is sponsored by University of Leicester. The principal investigator is Mark Orme, PhD at University of Leicester. The trial plans to enroll 30 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.